MSB 3.76% $1.03 mesoblast limited

Seeking Alpha (again)

  1. 7,702 Posts.
    lightbulb Created with Sketch. 11
    I know a lot of holders despise and malign this website  (Seeking Alpha) as desperate shorters determined to bring MSB down (bearing in mind neither a website nor shorts can bring a company down), and that's fair enough   - despising it -  but thought I'd post it anyway. In theory, at least, all views should be open to  - rational (?) discussion in an open Forum, especially, in what is soon to be an ASX  Publicly Listed Company (once again).
    Personally, I have no view whatsoever on the article (and currently no position in MSB), tho I have a long familiarity with the company  /stock, and a longstanding personal relationship with the founder.....(but not seen him for 2-3 years now)
    But some might be interested...Feel free to slam it.
    Mesoblast Is Trying To Fool Investors Again
    Summary

    The Phase 2 program in Rheumatoid Arthritis failed.
    We believe MESO performed post-hoc analysis to data-mine for positive endpoints.
    In our opinion, MESO has followed this same game plan to disastrous results in its Chronic Heart Failure trial.
    Short MESO for 80% downside.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.